UPDATE - 12/30/2014: Keller & Keller is no longer reviewing or able to accept client cases involving the drug Raplon. If you believe you have been harmed by Raplon, first contact your doctor and then seek alternate legal advice. If you have questions related to drug-litigation that does not involve Raplon, please contact us so that we can review your potential claim.
Raplon (rapacuronium bromide) is an anesthetic used to relax skeletal muscles during surgery. It was approved for use by the FDA in August of 1999. Raplon is being voluntarily pulled off the market by its manufacturer Organon, because it may cause death and severe breathing difficulties like bronchospasm.
Raplon was shown to have several adverse side effects. Raplon was linked with a condition known as bronchiospasm which if occurred during the procedure was serious and could produce fatal results. Warnings were issued to clinicians about the possible dangers of Raplon but it was decided that the risk was too great. In the clinical trials of Raplon 32 percent of the patients experienced some form of adverse reaction and letter after its usage was approved problems were experienced.
--difficulty breathing or wheezing
--fainting, dizziness or lightheadedness
--fast, slow or irregular heartbeat
--pain, redness, swelling or irritation at the injection site
--skin rash, hives or other unusual reaction
--unusual muscle weakness or tiredness
--flushing (reddening of the skin)
If you or a loved one has used the prescription drug Raplon and noticed adverse side effects, such as difficulty breathing, wheezing, dizziness, fainting, irregular heartbeat, rash, tiredness, fever or swelling, you should contact a physician immediately. If you wish to discuss your legal rights, are interested in more information on Raplon litigation, or if you have information about a Raplon case that you would like to share with us, please contact the law offices of Keller & Keller LLP for a free consultation concerning your potential rights. Keller & Keller LLP has office locations in Indiana, Michigan and New Mexico and will be able to evaluate your potential case at no cost to you.